Cagrilintide, an amylin analogue, is a promising medication for weight loss by enhancing satiety, delaying gastric emptying, and suppressing appetite. In my patients, I have also seen increased In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Does benadryl make you sleepy? Universal Drugstore Zepbound beats CagriSema in head to head trial : r Zepbound Retatrutide Legion inc Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine